The Risk of Missed Gastroesophageal Cancer Diagnoses in Users and Nonusers of Antisecretory Medication
- 1 October 2005
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 129 (4) , 1179-1186
- https://doi.org/10.1053/j.gastro.2005.07.028
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Empirical use of antisecretory drug therapy delays diagnosis of upper gastrointestinal adenocarcinoma but does not effect outcomeAlimentary Pharmacology & Therapeutics, 2004
- The long term results of endoscopic surveillance of premalignant gastric lesionsGut, 2002
- Surveillance and survival in Barrett's adenocarcinomas: A population-based studyGastroenterology, 2002
- Upper Gi Malignancy, Uncomplicated Dyspepsia, and The Age Threshold for Early EndoscopyAmerican Journal of Gastroenterology, 2002
- Outcome of oesophagogastric carcinoma in young patientsPostgraduate Medical Journal, 1999
- AGA technical review: Evaluation of dyspepsiaGastroenterology, 1998
- Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsiaGut, 1997
- Delays in the diagnosis of oesophagogastric cancer: a consecutive case seriesBMJ, 1997
- Gastric cancer: a curable disease in Britain.BMJ, 1993
- Early detection of gastric cancer.BMJ, 1990